Site-specific amino acid D-isomerization of Tau R2 and R3 peptides changes the fibril morphology, resulting in attenuation of Tau aggregation inhibitor potency
- 26 February 2023
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 654, 18-25
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (21K06498)
This publication has 32 references indexed in Scilit:
- The Many Faces of TauNeuron, 2011
- Amyloid-β and tau — a toxic pas de deux in Alzheimer's diseaseNature Reviews Neuroscience, 2010
- Tau protein and tau aggregation inhibitorsNeuropharmacology, 2010
- Three-/four-repeat-dependent aggregation profile of tau microtubule-binding domain clarified by dynamic light scattering analysisBiochemical and Biophysical Research Communications, 2009
- Different inhibitory response of cyanidin and methylene blue for filament formation of tau microtubule-binding domainBiochemical and Biophysical Research Communications, 2008
- Tau-mediated neurodegeneration in Alzheimer's disease and related disordersNature Reviews Neuroscience, 2007
- Fluorescence-coupled CD conformational monitoring of filament formation of tau microtubule-binding repeat domainBiochemical and Biophysical Research Communications, 2006
- Possible Role of Each Repeat Structure of the Microtubule-Binding Domain of the Tau Protein in In Vitro AggregationThe Journal of Biochemistry, 2005
- Neuritic Plaque Amyloid in Alzheimer's Disease Is Highly RacemizedJournal of Neurochemistry, 1988
- Physical and chemical properties of purified tau factor and the role of tau in microtubule assemblyJournal of Molecular Biology, 1977